These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36584205)

  • 1. Refinement of the extended crosswise model with a number sequence randomizer: Evidence from three different studies in the UK.
    Sayed KHA; Cruyff MJLF; van der Heijden PGM; Petróczi A
    PLoS One; 2022; 17(12):e0279741. PubMed ID: 36584205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys.
    Ulrich R; Pope HG; Cléret L; Petróczi A; Nepusz T; Schaffer J; Kanayama G; Comstock RD; Simon P
    Sports Med; 2018 Jan; 48(1):211-219. PubMed ID: 28849386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting nonadherence without loss in efficiency: A simple extension of the crosswise model.
    Heck DW; Hoffmann A; Moshagen M
    Behav Res Methods; 2018 Oct; 50(5):1895-1905. PubMed ID: 28916924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than random responding: Empirical evidence for the validity of the (Extended) Crosswise Model.
    Meisters J; Hoffmann A; Musch J
    Behav Res Methods; 2023 Feb; 55(2):716-729. PubMed ID: 35449499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O; Kuipers H; van Bottenburg M
    Sports Med; 2015 Jan; 45(1):57-69. PubMed ID: 25169441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UK Sport perspective on detecting growth hormone abuse.
    Stow MR; Wojek N; Marshall J
    Growth Horm IGF Res; 2009 Aug; 19(4):375-7. PubMed ID: 19487144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling social desirability bias: An experimental investigation of the extended crosswise model.
    Meisters J; Hoffmann A; Musch J
    PLoS One; 2020; 15(12):e0243384. PubMed ID: 33284820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized response estimates for doping and illicit drug use in elite athletes.
    Striegel H; Ulrich R; Simon P
    Drug Alcohol Depend; 2010 Jan; 106(2-3):230-2. PubMed ID: 19740612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sport motivation and doping in adolescent athletes.
    Mudrak J; Slepicka P; Slepickova I
    PLoS One; 2018; 13(10):e0205222. PubMed ID: 30286200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clarification of the Relationship between Awareness of Doping of Competitive Sports Coaches and Their Instructions to Prevent Doping].
    Yamaguchi T; Horio I; Goto M; Miyauchi Y; Izushi F
    Yakugaku Zasshi; 2016; 136(8):1185-93. PubMed ID: 27477736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of analytical finding of glycerol caused by self-catheterization in doping control.
    Okano M; Nishitani Y; Kageyama S
    Drug Test Anal; 2014; 6(11-12):1151-4. PubMed ID: 25079056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an empirical model of performance enhancing supplement use: a pilot study among high performance UK athletes.
    Mazanov J; Petróczi A; Bingham J; Holloway A
    J Sci Med Sport; 2008 Apr; 11(2):185-90. PubMed ID: 17350333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and experience of Kazakhstan athletes in anti-doping and the impact of past educational intervention.
    Zhumabayeva G; Kapanova G; Vinnikov D; Bakasheva M; Abdulla V; Grjibovski A
    Subst Abuse Treat Prev Policy; 2022 Apr; 17(1):32. PubMed ID: 35473576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intended or Unintended Doping? A Review of the Presence of Doping Substances in Dietary Supplements Used in Sports.
    Martínez-Sanz JM; Sospedra I; Ortiz CM; Baladía E; Gil-Izquierdo A; Ortiz-Moncada R
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28976928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.